Riliprubart Earns Orphan Drug Designation in the US for Antibody-mediated Rejection in Solid Organ Transplantation This designation reflects Sanofi’s commitment to addressing a critical unmet need in ...

Regular physical activity is essential for maintaining a healthy lifestyle, especially for seniors. However, only some people are comfortable going to the gym or exercising outdoors, especially during ...

• Process: To do RFLP analysis, researchers must dissolve DNA in an enzyme that breaks down the strand at specific locations. The length of each strand of DNA is affected by the number of repeats. The ...

Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo ...

Digital systems contain sensitive information, ranging from confidential business plans to private customer details, making security an essential requirement. However, excessive protections that ...

Selecting the appropriate nursing facility, also known as a nursing home, can be a challenging decision when considering the care of a parent. It’s important to recognize that no nursing home is ...

Today, Johnson & Johnson MedTech* announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson**, is launching a proprietary dual-use robotics and standalone navigation platform ...

Portal Biotech, a pioneering biotechnology company headquartered in London, today announced a $35 million Series A raise, representing one of Europe’s largest investments into a life sciences tools ...

The healthcare sector has experienced significant transformations in recent years. From taking responsibility in critical situations to developing patient engagement platforms, healthcare ...

The increase in geriatric population and disease incidences, primarily chronic diseases, has led to a surge in the demand for novel medical devices across multiple therapeutic areas. Since 2020, the ...

Conducted at Samsung Medical Center, the Phase 3 clinical trial enrolled 24 newly diagnosed Hunter Syndrome patients with no prior treatment. It evaluated the efficacy and safety of Hunterase over a ...

MiRus, LLC. reported that Pradeep K. Yadav MD, Director of Structural Interventions, Piedmont Heart Institute, Atlanta presented the initial experience with the MiRus Siegel™ 8-Fr aortic transcatheter ...